Eurobio Scientific S.A.
ALERS.PA · PAR
6/30/2025 | 12/31/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Market Cap | €258,775 | €258,775 | €141,178 | €150,667 |
| - Cash | €0 | €21,774 | €45,118 | €49,298 |
| + Debt | €0 | €34,055 | €93,403 | €100,631 |
| Enterprise Value | €258,775 | €271,056 | €189,463 | €202,000 |
| Revenue | €81,200 | €81,626 | €73,453 | €71,274 |
| % Growth | -0.5% | 11.1% | 3.1% | – |
| Gross Profit | €38,200 | €36,527 | €33,350 | €30,669 |
| % Margin | 47% | 44.7% | 45.4% | 43% |
| EBITDA | €10,557 | €8,185 | €11,492 | €13,820 |
| % Margin | 13% | 10% | 15.6% | 19.4% |
| Net Income | €2,400 | €1 | €3,999 | €2,644 |
| % Margin | 3% | 0% | 5.4% | 3.7% |
| EPS Diluted | 0.23 | 0 | 0.4 | 0.22 |
| % Growth | 229,900% | -100% | 81.8% | – |
| Operating Cash Flow | €0 | €8,991 | €7,712 | €15,362 |
| Capital Expenditures | €0 | -€1,533 | -€1,723 | -€1,395 |
| Free Cash Flow | €0 | €7,458 | €5,989 | €13,967 |